Macrolide resistance in the normal microbiota after Helicobacter pylori treatment

References

• Kuipers EJ, Thijs JC, Festen HP. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995; 9(Suppl 2)59–69
   PubMed Web of Science ®Google Scholar
• Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995; 9(Suppl 2)33–9
   PubMed Web of Science ®Google Scholar
• The European Helicobacter pylori Study Group, www.helicobacter.org.
   Google Scholar
• Parsonnet J, Harris RA H, Hack M, Owens DK. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 1996; 348: 150–4
   PubMed Web of Science ®Google Scholar
• Bergman M, Huikko S, Pihlajamaki M, Laippala P, Palva E, Huovinen P, et al. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997–2001. Clin Infect Dis 2004; 38: 1251–6
   PubMed Web of Science ®Google Scholar
• Seppala H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis 1995; 21: 1378–85
   PubMed Web of Science ®Google Scholar
• Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997; 337: 441–6
   PubMed Web of Science ®Google Scholar
• Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998; 280: 1233–7
   PubMed Web of Science ®Google Scholar
• Megraud F. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004; 53: 1374–84
   PubMed Web of Science ®Google Scholar
• Eady EA, Coates P, Ross JI, Ratyal AH, Cove JH. Antibiotic resistance patterns of aerobic coryneforms and furazolidone-resistant Gram-positive cocci from the skin surface of the human axilla and fourth toe cleft. J Antimicrob Chemother 2000; 46: 205–13
   PubMed Web of Science ®Google Scholar
• Kataja J, Huovinen P, Skurnik M, Seppala H. Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance. Antimicrob Agents Chemother 1999; 43: 48–52
   PubMed Web of Science ®Google Scholar
• Bryskier A. Viridans group streptococci: a reservoir of resistant bacteria in oral cavities. Clin Microbiol Infect 2002; 8: 65–9
   PubMed Web of Science ®Google Scholar
• Luna VA, Coates P, Eady EA, Cove JH, Nguyen TT, Roberts MC. A variety of Gram-positive bacteria carry mobile mef genes. J Antimicrob Chemother 1999; 44: 19–25
   PubMed Web of Science ®Google Scholar
• Fille M, Mango M, Lechner M, Schaumann R. Bacteroides fragilis group: trends in resistance. Curr Microbiol 2006; 52: 153–7
   PubMed Web of Science ®Google Scholar
• The Swedish Reference Group for Antibiotics, www.srga.org.
   Google Scholar
• Adamsson I, Nord CE, Lundquist P, Sjostedt S, Edlund C. Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. J Antimicrob Chemother 1999; 44: 629–40
   PubMed Web of Science ®Google Scholar
• Buhling A, Radun D, Muller WA, Malfertheiner P. Influence of anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora. Aliment Pharmacol Ther 2001; 15: 1445–52
   PubMed Web of Science ®Google Scholar
• Stark CA, Adamsson I, Edlund C, Sjosted S, Seensalu R, Wikstrom B, et al. Effects of omeprazole and amoxycillin on the human oral and gastrointestinal microflora in patients with Helicobacter pylori infection. J Antimicrob Chemother 1996; 38: 927–39
   PubMed Web of Science ®Google Scholar
• Matute AJ, Schurink CA, Krijnen RM, Florijn A M, Rozenberg-Arska M, Hoepelman IM. Double-blind, placebo-controlled study comparing the effect of azithromycin with clarithromycin on oropharyngeal and bowel microflora in volunteers. Eur J Clin Microbiol Infect Dis 2002; 21: 427–31
   PubMed Web of Science ®Google Scholar
• Sjolund M, Wreiber K, Andersson DI, Blaser MJ, Engstrand L. Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori. Ann Intern Med 2003; 139: 483–7
   PubMed Web of Science ®Google Scholar
• Lofmark, S, Jernberg, C, Jansson, JK, Edlund, C. Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes. J Antimicrob Chemother 2006;58:1160–7.
   PubMed Web of Science ®Google Scholar
• Bjorkman J, Hughes D, Andersson DI. Virulence of antibiotic-resistant Salmonella typhimurium. Proc Natl Acad Sci U S A 1988; 95: 3949–53
   Web of Science ®Google Scholar
• Hunt, RH, Huang, JQ. The case for treatment of dyspeptic patients infected with H. pylori. Eur J Surg Suppl 1998;6–10.
   PubMedGoogle Scholar
• McCarthy, DM. 1998. H. pylori infection in non-ulcer patients: to treat or not to treat. The case against treatment. Eur J Surg Suppl 1998;11–5
   PubMedGoogle Scholar
• McColl K, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, et al. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med 1998; 339: 1869–74
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Feltbower R, Brown J, Mason S, Mason J, Nathan J, et al. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomized controlled trial. Leeds HELP Study Group. Lancet 2000; 355: 1665–9
   PubMed Web of Science ®Google Scholar
• Moayyedi, P, Soo, S, Deeks, J, Delaney, B, Harris, A, Innes, M, , et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev:CD002096.2006.
   Google Scholar
• Moayyedi P, Soo S, Deeks J, Forman D, Mason J, Innes M, et al. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. Br Med J 2000; 321: 659–64
   PubMed Web of Science ®Google Scholar